Show simple item record

dc.contributor.authorGheghiani, L
dc.contributor.authorLoew, D
dc.contributor.authorLombard, B
dc.contributor.authorMansfeld, J
dc.contributor.authorGavet, O
dc.date.accessioned2020-08-26T13:26:01Z
dc.date.issued2017-06-06
dc.identifier.citationCell reports, 2017, 19 (10), pp. 2060 - 2073
dc.identifier.issn2211-1247
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4016
dc.identifier.eissn2211-1247
dc.identifier.doi10.1016/j.celrep.2017.05.031
dc.description.abstractCommitment to mitosis must be tightly coordinated with DNA replication to preserve genome integrity. While we have previously established that the timely activation of CyclinB1-Cdk1 in late G2 triggers mitotic entry, the upstream regulatory mechanisms remain unclear. Here, we report that Polo-like kinase 1 (Plk1) is required for entry into mitosis during an unperturbed cell cycle and is rapidly activated shortly before CyclinB1-Cdk1. We determine that Plk1 associates with the Cdc25C1 phosphatase and induces its phosphorylation before mitotic entry. Plk1-dependent Cdc25C1 phosphosites are sufficient to promote mitotic entry, even when Plk1 activity is inhibited. Furthermore, we find that activation of Plk1 during G2 relies on CyclinA2-Cdk activity levels. Our findings thus elucidate a critical role for Plk1 in CyclinB1-Cdk1 activation and mitotic entry and outline how CyclinA2-Cdk, an S-promoting factor, poises cells for commitment to mitosis.
dc.formatPrint
dc.format.extent2060 - 2073
dc.languageeng
dc.language.isoeng
dc.publisherCELL PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHela Cells
dc.subjectHumans
dc.subjectProtein-Serine-Threonine Kinases
dc.subjectCDC2 Protein Kinase
dc.subjectCell Cycle Proteins
dc.subjectProto-Oncogene Proteins
dc.subjectMitosis
dc.subjectG2 Phase
dc.subjectCyclin B1
dc.subjectCyclin A2
dc.subjectHEK293 Cells
dc.titlePLK1 Activation in Late G2 Sets Up Commitment to Mitosis.
dc.typeJournal Article
dcterms.dateAccepted2017-05-09
rioxxterms.versionofrecord10.1016/j.celrep.2017.05.031
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfCell reports
pubs.issue10
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Post-translational modifications and cell proliferation
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Post-translational modifications and cell proliferation
pubs.publication-statusPublished
pubs.volume19
pubs.embargo.termsNo embargo
icr.researchteamPost-translational modifications and cell proliferation
dc.contributor.icrauthorMansfeld, Joerg


Files in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0